145 related articles for article (PubMed ID: 11912548)
41. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
[TBL] [Abstract][Full Text] [Related]
42. Autoantibodies against oxidized low-density lipoprotein correlate with Achilles tendon xanthomas.
Okada M; Miida T; Fujiwara A; Inomata N
Clin Chem Lab Med; 2000 Jun; 38(6):501-6. PubMed ID: 10987197
[TBL] [Abstract][Full Text] [Related]
43. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
Yadav R; Liu Y; Kwok S; Hama S; France M; Eatough R; Pemberton P; Schofield J; Siahmansur TJ; Malik R; Ammori BA; Issa B; Younis N; Donn R; Stevens A; Durrington P; Soran H
J Am Heart Assoc; 2015 Sep; 4(9):e001508. PubMed ID: 26374297
[TBL] [Abstract][Full Text] [Related]
44. Cameroonian professional soccer players and risk of atherosclerosis.
Nansseu JR; Ama Moor VJ; Takam RDM; Zing-Awona B; Azabji-Kenfack M; Tankeu F; Tchoula CM; Moukette BM; Ngogang JY
BMC Res Notes; 2017 Jun; 10(1):186. PubMed ID: 28577561
[TBL] [Abstract][Full Text] [Related]
45. Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes.
Griffin ME; McInerney D; Fraser A; Johnson AH; Collins PB; Owens D; Tomkin GH
Diabet Med; 1997 Sep; 14(9):741-7. PubMed ID: 9300223
[TBL] [Abstract][Full Text] [Related]
46. Analyzing of high-density lipoprotein subfractions and low-density lipoprotein subfractions in human serum with anion-exchange chromatography.
Hirowatari Y; Tsunoda Y; Ogura Y; Homma Y
Atherosclerosis; 2009 Jun; 204(2):e52-7. PubMed ID: 19091316
[TBL] [Abstract][Full Text] [Related]
47. Autoantibodies against low-density lipoprotein and atherogenic potential of blood.
Kacharava AG; Tertov VV; Orekhov AN
Ann Med; 1993 Dec; 25(6):551-5. PubMed ID: 8292305
[TBL] [Abstract][Full Text] [Related]
48. Plasma kinetics of an LDL-like non-protein nanoemulsion and transfer of lipids to high-density lipoprotein (HDL) in patients with rheumatoid arthritis.
Pozzi FS; Maranhão RC; Guedes LK; Borba EF; Laurindo IM; Bonfa E; Vinagre CG
J Clin Lipidol; 2015; 9(1):72-80. PubMed ID: 25670363
[TBL] [Abstract][Full Text] [Related]
49. Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy.
Atchley DH; Lopes-Virella MF; Zheng D; Kenny D; Virella G
Diabetologia; 2002 Nov; 45(11):1562-71. PubMed ID: 12436340
[TBL] [Abstract][Full Text] [Related]
50. Significantly higher levels of oxidized LDL autoantibody in coronary artery disease patients.
Liang KW; Huang JL; Kao CH; Hsueh CW; Ho HY; Lee WL; Wang KY; Huang DS; Chen YT; Ting CT
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):101-6. PubMed ID: 10677919
[TBL] [Abstract][Full Text] [Related]
51. Oxidized low-density lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population.
Chen HW; Kuo CL; Huang CS; Kuo SJ; Liu CS
Cardiology; 2008; 110(4):252-9. PubMed ID: 18073481
[TBL] [Abstract][Full Text] [Related]
52. Serum lipids and lipoprotein disorders in cancer patients.
Alexopoulos CG; Blatsios B; Avgerinos A
Cancer; 1987 Dec; 60(12):3065-70. PubMed ID: 3677028
[TBL] [Abstract][Full Text] [Related]
53. Association between plasma oxidized low-density lipoprotein and diabetic nephropathy.
Ujihara N; Sakka Y; Takeda M; Hirayama M; Ishii A; Tomonaga O; Babazono T; Takahashi C; Yamashita K; Iwamoto Y
Diabetes Res Clin Pract; 2002 Nov; 58(2):109-14. PubMed ID: 12213352
[TBL] [Abstract][Full Text] [Related]
54. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.
Dobiásová M; Raslová K; Rauchová H; Vohnout B; Ptácková K; Frohlich J
Physiol Res; 2001; 50(1):1-8. PubMed ID: 11300220
[TBL] [Abstract][Full Text] [Related]
55. Antibodies to oxidized lipoproteins and their relationship to myocardial infarction.
Ryan M; Owens D; Kilbride B; Collins P; Johnson A; Tomkin GH
QJM; 1998 Jun; 91(6):411-5. PubMed ID: 9709459
[TBL] [Abstract][Full Text] [Related]
56. Plasma levels of antibodies against oxidized LDL are inherited but not associated with HDL-cholesterol level in families with early coronary heart disease.
Paavola T; Kangas-Kontio T; Salonurmi T; Kuusisto S; Huusko T; Savolainen MJ; Kakko S
Atherosclerosis; 2012 Sep; 224(1):123-8. PubMed ID: 22818623
[TBL] [Abstract][Full Text] [Related]
57. Effect of vitamin E supplementation on antibody levels against malondialdehyde modified LDL in hyperlipidemic hamsters.
de Oliveira FG; Rossi CL; de Oliveira MG; Saad MJ; Velloso LA
Cardiovasc Res; 2000 Aug; 47(3):567-73. PubMed ID: 10963729
[TBL] [Abstract][Full Text] [Related]
58. Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome.
Demirel F; Bideci A; Cinaz P; Camurdan MO; Biberoğlu G; Yesilkaya E; Hasanoğlu A
Clin Endocrinol (Oxf); 2007 Jul; 67(1):129-34. PubMed ID: 17465999
[TBL] [Abstract][Full Text] [Related]
59. Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases.
Cai HJ; Li ZX; Yang SM
Atherosclerosis; 1982 Jun; 43(2-3):197-207. PubMed ID: 7115460
[TBL] [Abstract][Full Text] [Related]
60. CETP and oxidized LDL levels increase in dyslipidemic subjects.
Wang J; Gu Q; Li K; Zhang C
Clin Biochem; 2007 Sep; 40(13-14):995-9. PubMed ID: 17658505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
